Supplementary Material for ECCO 2025 Scientific Presentations
Year: 2025
Type: supplementary-materials
Abstract: Congress materials may include information for investigational products or for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Regulatory approval of investigational products or uses is dependent on the completion of the study programs and review by regulatory authorities. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Source: Figshare
Author: Fellmann, Marc
Language: English
Open Access status: green
OpenAlex ID: W6963491157
Cites:
Cited by:
Related to: